WO2000074714A3 - Indicators for monitoring the technique of transcutaneous immunization - Google Patents

Indicators for monitoring the technique of transcutaneous immunization Download PDF

Info

Publication number
WO2000074714A3
WO2000074714A3 PCT/US2000/015183 US0015183W WO0074714A3 WO 2000074714 A3 WO2000074714 A3 WO 2000074714A3 US 0015183 W US0015183 W US 0015183W WO 0074714 A3 WO0074714 A3 WO 0074714A3
Authority
WO
WIPO (PCT)
Prior art keywords
indicators
monitoring
technique
immunization
transcutaneous immunization
Prior art date
Application number
PCT/US2000/015183
Other languages
French (fr)
Other versions
WO2000074714A2 (en
Inventor
Gregory M Glenn
Original Assignee
Gregory M Glenn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gregory M Glenn filed Critical Gregory M Glenn
Priority to AU53150/00A priority Critical patent/AU5315000A/en
Publication of WO2000074714A2 publication Critical patent/WO2000074714A2/en
Publication of WO2000074714A3 publication Critical patent/WO2000074714A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

Transcutaenous immunization system delivers antigen to immune cells through topical application, and induces an antigen-specific immune response in an animal or human. The improvement involves a system for marking the successful delivery of the immunization using indicators or using marking systems to allow better application of the patch to a prepared skin surface.
PCT/US2000/015183 1999-06-03 2000-06-02 Indicators for monitoring the technique of transcutaneous immunization WO2000074714A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU53150/00A AU5315000A (en) 1999-06-03 2000-06-02 Indicators for monitoring the technique of transcutaneous immunization

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13779099P 1999-06-03 1999-06-03
US60/137,790 1999-06-03

Publications (2)

Publication Number Publication Date
WO2000074714A2 WO2000074714A2 (en) 2000-12-14
WO2000074714A3 true WO2000074714A3 (en) 2001-07-05

Family

ID=22479050

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/015183 WO2000074714A2 (en) 1999-06-03 2000-06-02 Indicators for monitoring the technique of transcutaneous immunization

Country Status (2)

Country Link
AU (1) AU5315000A (en)
WO (1) WO2000074714A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911742B2 (en) 1996-11-14 2014-12-16 The United States Of America As Represented By The Secretary Of The Army Transcutaneous immunization without heterologous adjuvant

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004525921A (en) * 2001-03-19 2004-08-26 イオマイ コーポレイシヨン Transdermal immunization patch
DE102004001558A1 (en) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Medicinal products for topical application in animals

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1600332A (en) * 1968-12-31 1970-07-20
US4152412A (en) * 1976-04-02 1979-05-01 Brewer John H Marking vaccine
US5667798A (en) * 1993-12-30 1997-09-16 Harrogate Holdings, Limited Transdermal drug delivery system
WO1998020734A1 (en) * 1996-11-14 1998-05-22 The Government Of The United States Of America, As Represented By The Secretary Of The Army Adjuvant for transcutaneous immunization

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1600332A (en) * 1968-12-31 1970-07-20
US4152412A (en) * 1976-04-02 1979-05-01 Brewer John H Marking vaccine
US5667798A (en) * 1993-12-30 1997-09-16 Harrogate Holdings, Limited Transdermal drug delivery system
WO1998020734A1 (en) * 1996-11-14 1998-05-22 The Government Of The United States Of America, As Represented By The Secretary Of The Army Adjuvant for transcutaneous immunization

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, vol. 52, no. 6, 1995, pages 489 - 495, ISSN: 0002-9637 *
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1995, MATTER HANS C ET AL: "Test of three bait types for oral immunization of dogs against rabies in Tunisia.", XP002156999, Database accession no. PREV199598430950 *
GLENN G M ET AL: "Skin immunization made possible by cholera toxin [letter]", NATURE,GB,MACMILLAN JOURNALS LTD. LONDON, vol. 391, no. 6670, 26 February 1998 (1998-02-26), pages 851, XP002110053, ISSN: 0028-0836 *
GLENN G M ET AL: "Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants", INFECTION AND IMMUNITY,US,AMERICAN SOCIETY FOR MICROBIOLOGY. WASHINGTON, vol. 67, no. 3, March 1999 (1999-03-01), pages 1100 - 1106, XP002110054, ISSN: 0019-9567 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911742B2 (en) 1996-11-14 2014-12-16 The United States Of America As Represented By The Secretary Of The Army Transcutaneous immunization without heterologous adjuvant

Also Published As

Publication number Publication date
WO2000074714A2 (en) 2000-12-14
AU5315000A (en) 2000-12-28

Similar Documents

Publication Publication Date Title
WO2000061184A3 (en) Dry formulation for transcutaneous immunization
CA2272417A1 (en) Adjuvant for transcutaneous immunization
WO2001098335A3 (en) Transgenic algae for delivering antigens to an animal
AU3593597A (en) Medical adhesive bandage, delivery system and method
ATE270880T1 (en) STOMACH-RESIDING MICROSPHERES WITH CONTROLLED RELEASE FOR IMPROVED DRUG DELIVERY
AU2279401A (en) Intelligent transceiving method, device and system
HUP9901562A3 (en) Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system
AU6341298A (en) Ultrasonic catheter, system and method for two-dimensional imaging or three-dimensional reconstruction
AU5782900A (en) Secure, limited-access database system and method
BRPI0511604A (en) electrical communication unit, electrical communication system, and, use of electrical communication unit or electrical communication system
PT1137436E (en) Stimulation of t-cells against self antigens using ctla-4 blocking agents
AP2000001762A0 (en) Method of delivering genes to antigen presenting cells of the skin
AU4336597A (en) Ultrasonic energy delivery system and method
ATE238778T1 (en) TRANSDERMAL THERAPEUTIC SYSTEM FOR THE RELEASE OF HORMONES
AU2938100A (en) Transdermal drug delivery system and method
EP1036573A4 (en) Device for delivering drug through skin or mucosa
AU7634801A (en) Three-dimensional skin model
AU2187497A (en) Device for injecting a substance into a body, especially human or animal
HK1026148A1 (en) Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation.
ZA988186B (en) Baggage pusher device, system and method of use.
WO1999027948A3 (en) Use of soluble recombinant human cd40l protein for inhibiting in vivo immune response
MXPA01012475A (en) System and method for delivering a medical treatment to a treatment site.
WO2000074714A3 (en) Indicators for monitoring the technique of transcutaneous immunization
NO20000814L (en) Identification of adhesive surface-shaped dermal and transdermal therapeutic dosage forms using an adhesive patch as an information carrier, as well as methods of their preparation
ZA200203294B (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP